Although several macrolide antibiotics are proarrhythmic and associated with an increased
risk of sudden cardiac death, azithromycin is thought to have minimal cardiotoxicity.
However, published reports of arrhythmias suggest that azithromycin
may increase the risk of cardiovascular death.